Latest papers

HIV pathogenesis: 25 years of progress and persistent challenges.

Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors.

Elite controllers found to have more lethal CD8+ T cells.

Deletion, insertion and stop codon mutations in vif genes of HIV-1 infecting slow progressor patients.

Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers.

[Linking Nef with the immunological and virological determinants of AIDS].

Genetic correlates of protection against HIV infection: the ally within.

Spirit of Excellence Award for Team--honorable mention. Something to talk about.

Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.

[Carrying certain KIR3DL1 alleles with HLA-B*57 is associated with protection from HIV infection].

Nef mutations in long-term non-progressors from former plasma donors infected with HIV-1 subtype B in China.

County-level socioeconomic status and survival after HIV diagnosis, United States.

A very particular case of long-term non-progressor: nineteen consecutive years of follow-up in the absence of any detectable HIV-1 viraemia.

Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors.

Differences in perceptions on sexual and reproductive health between service providers and people living with HIV: a qualitative elicitation study.

Holding back the years.

HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors.

No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors.

Quality of life of people living with HIV and AIDS in Estonia.

Encouraging innovation: ten research priorities for achieving universal access to HIV/AIDS prevention, treatment and care in Europe by 2010.